Status:
UNKNOWN
EFFECT OF COGNITIVE BEHAVIORAL THERAPY ON DEPRESSION AND QUALITY OF LIFE IN PATIENTS WITH POST COVID-19
Lead Sponsor:
Cairo University
Conditions:
Post-COVID-19 Syndrome
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to test the effect of Rehacom on depression and Quality of life in post covid -19 patients. The main question it aims to answer is: • Is a cognitive rehabilitation ...
Detailed Description
Purpose of the study: * To investigate the effect of cognitive rehabilitation therapy on depression in post COVID-19 patients. * To investigate the effect of cognitive rehabilitation therapy on quali...
Eligibility Criteria
Inclusion
- All patients will be selected according to following criteria:
- Patients from both genders (male and female).
- The age of participants ranged from 30 to 45 years .
- The patients had score more than 24 according to Mini mental state examination (MMSE).
- Patient muscle power not less than grade 3 .
- Patients are ambulant.
- Patients with confirmation of previous covid19 infection PCR TEST.
- Participants were required to live in Egypt during the pre-covid and COVID-19 pandemic.
- Patients meeting the guide line of world health organization (WHO) of long/post-covid 19 syndromes.
- Patients are "long-haulers" those who history of probable or confirmed SARS-CoV-2 infection; usually within three months from the onset of COVID-19, and last more than two months
Exclusion
- The patients will be excluded if they have any of the following:
- Patient previously diagnosed with depression and currently taking medication.
- patient had prior cognitive impairment.
- Illiterate patients.
- patient had experienced another major stressful event (e.g., divorce, bereavement) in the past year.
- Checking comorbidities (sum of hypertension, diabetes, arrhythmia, myocardial infarction, Chronic Obstructive Pulmonary Disease/Asthma.
- Mild cognitive impairment, dementia, other neurodegenerative diseases, stroke, depression,
- Osteoarthritis , low back pain and prevalence of polypharmacy (5 or more drugs) at admission.
Key Trial Info
Start Date :
May 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05981872
Start Date
May 4 2023
End Date
January 1 2024
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of physical therapy .Cairo university
Cairo, Egypt, 4240101